<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013282</url>
  </required_header>
  <id_info>
    <org_study_id>13.0020.02</org_study_id>
    <nct_id>NCT04013282</nct_id>
  </id_info>
  <brief_title>Adrenergic Cholinergic Enteric Measures/Mapping</brief_title>
  <acronym>ACEM</acronym>
  <official_title>Adrenergic Cholinergic Enteric Measures/Mapping</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients seen who had autonomic and enteric profiling (Adrenergic, Cholinergic, Enteric&#xD;
      Measures/Mapping=ACEM_ from 2012-2019 at the University of Louisville.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patients seen who had autonomic and enteric profiling (Adrenergic Cholinergic Enteric&#xD;
           Measures/Mapping=ACEM) from 2012-2019 at the U of Louisville.&#xD;
&#xD;
        2. Results of the physiologic measures of ACEM had the results recorded.&#xD;
&#xD;
        3. ACEM is compared to standardized gastric emptying values as the primary measure.&#xD;
&#xD;
        4. ACEM is also compared to metabolic measures of weight, height and thus BMI as a&#xD;
           secondary measure.&#xD;
&#xD;
        5. ACEM is aloes compared with standardized gastrointestinal symptoms by a traditional&#xD;
           patient recorded outcome as another secondary measure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 1, 2012</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>10 years</time_frame>
    <description>We calculate Body Mass Index (BMI) using the following formula:&#xD;
weight (kg) / [height (m)] squared&#xD;
BMI is weight in kilograms divided by height in meters squared.</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Obesity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients seen&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with the symptoms suggestive of autonomic and/or enteric disorders.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anatomic obstruction of the GI tract&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inability of patient or guardian to sign informed consent, if needed&#xD;
&#xD;
          -  Psychiatric disorders precluding assessment and treatment of the patient's GI&#xD;
             condition.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Abell</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas L Abell</last_name>
    <phone>(502)852-6991</phone>
    <email>thomas.abell@louisville.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Abell, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>November 6, 2020</last_update_submitted>
  <last_update_submitted_qc>November 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Thomas Abell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

